Stay updated with breaking news from Nasdaq Gene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genetic Technologies Limited (NASDAQ:GENE – Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 28,100 shares, an increase of 19.6% from the December 31st total of 23,500 shares. Based on an average trading volume of 23,700 shares, […]
Shares of Genetic Technologies Limited (NASDAQ:GENE – Free Report) are scheduled to reverse split before the market opens on Monday, December 4th. The 1-5 reverse split was announced on Monday, December 4th. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, December 4th. Genetic Technologies Stock Performance NASDAQ […]
Genetic Technologies Limited (NASDAQ:GENE – Get Free Report) was the target of a large increase in short interest in August. As of August 31st, there was short interest totalling 64,700 shares, an increase of 22.3% from the August 15th total of 52,900 shares. Based on an average daily volume of 67,700 shares, the short-interest ratio […]
Genetic Technologies (NASDAQ:GENE – Get Free Report) and Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk and valuation. Analyst Ratings This is a summary of […]
Genetic Technologies (NASDAQ:GENE – Get Free Report) and Applied DNA Sciences (NASDAQ:APDN – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations. Institutional & Insider Ownership 0.9% of […]